Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment

International Journal of Hyperthermia

Volumn 12, Issue 2, 1996, Pages 211-222

  Raaphorst, G P ^a   Chabot, P ^a   Doja, S ^a   Wilkins, D ^a   Stewart, D ^a   Ng, C E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin resistance; Glioma; Growth phase; Hyperthermia; Ovarian carcinoma

Indexed keywords

CISPLATIN;

ARTICLE; CELL GROWTH; CELL SURVIVAL; DRUG SENSITIVITY; GLIOMA; HEATING; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; OVARY CARCINOMA; TUMOR CELL LINE;

EID: 0029981554     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609022510     Document Type: Article

References (28)

1. ATEMA, A., BUURMAN, K. J. H., NOTEBOOM, E., and SMETS, L. A., 1993, Potentiation of DNA-adduct formation and cytotoxicity of platinum - containing drugs by low pH. International Journal of Cancer, 54, 166-172.
2. BOITREL, M. T. D., PELLETIER, H., GENNE, P., PETIT, J. M., LE GRIMELLEC, C., CANAL, P., ARDIET, C., BASTIAN, G., and CHAUFFERT, B., 1992, Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells. International Journal of Cancer, 50, 677-682.
3. BOWDEN, G. T., KASUNIC, M., and DIM, D., 1983, Sequence dependence for the hyperthermic potentiation of cis-diaminedichloroplatinum(II) induced cytotoxicity and DNA damage. Proceedings of the 3rd NAGH, pp. 161-162.
4. CANON, J. L., HUMBLET, Y., and SYMANN, M., 1990, Resistance to cisplatin: How to deal with the problem? European Journal of Cancer, 26, 1-3.
5. DASILVA, V. F., RAAPHORST, G. P., GOYAL, R., and FEELEY, M. M., 1987, Drug cytotoxicity at elevated temperature. Journal of Neurosurgery, 67, 83-88.
6. DOUPLE, E. G., STROHBEHN, J. W., DESIEYES, D. C., and ALBOROUGH, D. P., 1982, Therapeutic potentiation of cis-diaminedichloroplatinum in a mouse tumour. National Cancer Institute Monograms, 61, 259-262.
7. EASTMAN, A., and SCHULTE, N., 1988, Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum(II). Biochemistry, 27, 4730-4734.
8. EICHHOLTZ-WIRTH, H., and HIETEL, B., 1990, Heat sensitization to cisplatin in two cell lines with different drug sensitivities. International Journal of Hyperthermia, 6, 47-55.
9. ENGELHARDT, R., 1987, Hyperthermia and drugs. Recent Results in Cancer Research, 104, 136-203.
10. FRAVAL, H. N. A., and ROBERTS, J. J., 1979, G1 Phase Chinese Hamster V79-379A cells are inherently more sensitive to platinum bound to their DNA than mid S Phase or asynchronously treated cells. Biochemical Pharmacology, 28, 1575-1580.
11. HAHN, G. M., 1979, Potentiation of therapy drugs and hyperthermia. Cancer Research, 39, 2264-2268.
12. HAMILTON, T. C., LAI, G. M., ROTHENBERG, L. M., FOJO, A. T., YOUNG, R. C., and OZOLS, R. F., 1989, Mechanisms of resistance to cisplatin and alkylating agents. In Drug Resistance in Cancer Therapy, edited by R. F. Ozols (Boston: Kiuwer Academic Publishers).
13. HERMAN, T. S., SWEETS, C. C., WHITE, D. M., and GERNER, E. W., 1982, Effect of rate of heating on lethality due to hyperthermia and selected chemotherapy drugs. Journal of the National Cancer Institute, 68, 487-492.
14. HERMAN, T. S., TEICHER, B. A., CATHCART, F. N. S., KAUFMAN, M. E., LEE, J. B., and LEE, M., 1988. Effect of hyperthermia on cisdiaminedichloroplatinum(II) and pt(Rh-123) in a human squamous carcinoma cell line and a cisplatin resistant subline. Cancer Research, 48, 5101-5105.
15. KONINGS, A. W. T., HETTINGA, J. V. E., LEMSTRA, W., HUMPHREY, G. B., and KAPINGA, H. H., 1993, Sensitizing for cisplatin action by hyperthermia in resistant cells. International Journal of Hyperthermia, 9, 553-562.
16. 1 or late S phase. Cancer Research, 53, 1239-1243.
17. KUBOTA, N., KAKEHI, M., and INADA, T., 1993, Hyperthermic enhancement of cell killing by five platinum complexes in human malignant cells grown as monolayer cultures and multi-cellular spheroids. International Journal of Radiation Oncology, 25, 491-497.
18. LAI, G. M., OZOLS, R. F., SMYTH, J. F., YOUNG, R. C., and HAMILTON, T. C., 1988, Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochemical Pharmacology, 37, 4597-4600.
19. LAURENCOT, C. M., and KENNEDY, K. A., 1992, Cisplatin Toxicity in EMT6 mouse mammary tumour cells after alterations in extracellular pH and intracellular pH. Proceedings of the Annual Meeting of the American Association of Cancer Research, 33, A3212.
20. MASUDA, H., TANASCA, T., KIDO, A., KITAMURA, K., and KUSABA, I., 1991, Hyperthermic enhancement of cytotoxicity and DNA-binding of cisplatin in sensitive and resistant human ovarian cancer cell lines. Cancer Journal, 4, 283-287.
21. MEIJER, C., MULDER, N. H., HOSPERS, G. A. P., UGES, D. R. A., and DE VRIES, E. G. E., 1990, The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. British Journal of Cancer, 62, 72-77.
22. MICETICH, K., ZWELLING, L., and KOHN, K. W., 1983, Quenching of DNA: platinum(II) monoadducts as a possible mechanism of resistance to cis-diaminedichloroplatinum(II) in L1210 cells. Cancer Research, 43, 3609-3613.
23. MIYAHARA, T., UEDA, K., AKABOSHI, M., SHIMADA, Y., IMAMURA, M., and UTSUMI, H., 1993, Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diaminedichloroplatinum(II) in cultured human esophageal cancer cells. Japan Journal of Cancer Research, 84, 336-346.
24. SUPI, G., BADARACCO, G., CAVATIERE, R., NATALI, F. G., and GERCO, C., 1994, Influence of sequence on hyperthermia and drug combination. Hyperthermic Oncology, 1, 429-431.
25. TASHIRO, T., and SATO, Y., 1992, Chracterization of acquired resistance to cis-diaminedichloroplatinum(I) in mouse leukemia cell lines. Japan Journal of Cancer Research, 83, 219-225.
26. URANO, M., KAHN, J., and KENTON, L. A., 1990. The effect of cisplatin I treatment at elevated temperatures on murine fibrosarcoma. F.Sa-II. International Journal of Hyperthermia, 6, 563-570.
27. WALLNER, K. E., and LI, G. C., 1987, Effect of drug exposure duration and sequencing on Hyperthermic potentiation of Metomycin-C and Cisplatin. Cancer Research. 47, 493-495.
28. WESTERMARK, B., PONTEN, J., and HUGOSSEN, R., 1973, Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathology Microbiology Scandinavia, 81, 791-805.